Literature DB >> 35917881

Long non-coding RNA G23Rik attenuates fasting-induced lipid accumulation in mouse liver.

Donghwan Kim1, Bora Kim1, Chad N Brocker1, Kritika Karri2, David J Waxman2, Frank J Gonzalez3.   

Abstract

Peroxisome proliferator-activated receptor α (PPARα) is a key mediator of lipid metabolism and metabolic stress in the liver. A recent study revealed that PPARα-dependent long non-coding RNAs (lncRNAs) play an important role in modulating metabolic stress and inflammation in the livers of fasted mice. Here hepatic lncRNA 3930402G23Rik (G23Rik) was found to have active peroxisome proliferator response elements (PPREs) within its promoter and is directly regulated by PPARα. Although G23Rik RNA was expressed to varying degrees in several tissues, the PPARα-dependent regulation of this lncRNA was only observed in the liver. Pharmacological activation of PPARα induced PPARα recruitment at the G23Rik promoter and a pronounced increase in hepatic G23Rik lncRNA expression. A G23Rik-null mouse line was developed to further characterize the function of this lncRNA in the liver. G23Rik-null mice were more susceptible to hepatic lipid accumulation in response to acute fasting. Histological analysis further revealed a pronounced buildup of lipid droplets and a significant increase in neutral triglycerides and lipids as indicated by enhanced oil red O staining of liver sections. Hepatic cholesterol, non-esterified fatty acid, and triglyceride levels were significantly elevated in G23Rik-null mice and associated with induction of the lipid-metabolism related gene Cd36. These findings provide evidence for a lncRNA dependent mechanism by which PPARα attenuates hepatic lipid accumulation in response to metabolic stress through lncRNA G23Rik induction. Published by Elsevier B.V.

Entities:  

Keywords:  Fasting; G23Rik; LncRNA; PPARA

Mesh:

Substances:

Year:  2022        PMID: 35917881      PMCID: PMC9561029          DOI: 10.1016/j.mce.2022.111722

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.369


  37 in total

1.  Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells.

Authors:  Fei Chen; Jianing Chen; Linbin Yang; Jiang Liu; Xiaoqian Zhang; Yin Zhang; Qingqiang Tu; Dong Yin; Dechen Lin; Ping-Pui Wong; Di Huang; Yue Xing; Jinghua Zhao; Mengfeng Li; Qiang Liu; Fengxi Su; Shicheng Su; Erwei Song
Journal:  Nat Cell Biol       Date:  2019-04-01       Impact factor: 28.824

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

Review 3.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  Activation of Male Liver Chromatin Accessibility and STAT5-Dependent Gene Transcription by Plasma Growth Hormone Pulses.

Authors:  Jeannette Connerney; Dana Lau-Corona; Andy Rampersaud; David J Waxman
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

Review 5.  Serum Amyloid A (SAA) Proteins.

Authors:  George H Sack
Journal:  Subcell Biochem       Date:  2020

6.  Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Authors:  Tao Fang; Meiling Cui; Ji Sun; Chao Ge; Fangyu Zhao; Lin Zhang; Hua Tian; Lixing Zhang; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Hong Li; Jinjun Li
Journal:  Oncotarget       Date:  2015-06-30

Review 7.  Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.

Authors:  Anastasia Asimakopoulou; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Front Physiol       Date:  2016-09-27       Impact factor: 4.566

8.  Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.

Authors:  Yanyong Xu; Yingdong Zhu; Kavita Jadhav; Yuanyuan Li; Huihui Sun; Liya Yin; Takhar Kasumov; Xiaoli Chen; Yanqiao Zhang
Journal:  Hepatol Commun       Date:  2019-03-25

Review 9.  Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases.

Authors:  Doortje W Dekens; Ulrich L M Eisel; Leonie Gouweleeuw; Regien G Schoemaker; Peter P De Deyn; Petrus J W Naudé
Journal:  Ageing Res Rev       Date:  2021-07-26       Impact factor: 10.895

10.  Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting.

Authors:  Chad N Brocker; Donghwan Kim; Tisha Melia; Kritika Karri; Thomas J Velenosi; Shogo Takahashi; Daisuke Aibara; Jessica A Bonzo; Moshe Levi; David J Waxman; Frank J Gonzalez
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.